BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6315556)

  • 1. Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells.
    Stachura J; Konturek SJ; Cieszkowsky M; Dabroś W; Zakrzewska J; Konturek J
    Hepatogastroenterology; 1983 Oct; 30(5):205-10. PubMed ID: 6315556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
    Okabe S; Shimosako K; Amagase K
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
    Batzri S; Brugada O; Harmon JW; Rich NM
    J Pharmacol Exp Ther; 1988 Aug; 246(2):493-9. PubMed ID: 2841448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
    Palumbo GJ; Nielsen ST
    Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs.
    Konturek SJ; Cieszkowski M; Kwiecień N; Konturek J; Tasler J; Bilski J
    Gastroenterology; 1984 Jan; 86(1):71-7. PubMed ID: 6689674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
    Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
    Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine in stress ulcer prophylaxis in rats.
    Warzecha Z; Dembiński A; Brzozowski T; Ceranowicz P; Dembiński M; Stachura J; Konturek SJ
    J Physiol Pharmacol; 2001 Sep; 52(3):407-21. PubMed ID: 11596859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
    Nagaya H; Satoh H; Maki Y
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1289-95. PubMed ID: 2156997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole, cimetidine, and ranitidine: inhibition of acid production in isolated human parietal cells.
    Gustavsson S; Mårdh S; Norberg L; Nyrén O; Wollert S
    Scand J Gastroenterol; 1985 Oct; 20(8):917-21. PubMed ID: 4081628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of omeprazole and ranitidine on gastric acid secretion, blood gastrin levels and [3H]-thymidine incorporation in the oxyntic mucosa from dogs and rats.
    Ryberg B; Mattsson H; Carlsson E
    Digestion; 1988; 39(2):91-9. PubMed ID: 3410171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
    Larson GM; Sullivan HW; Rayford PL
    Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclo-oxygenase-1 inhibition increases acid secretion by modulating H+,K+-ATPase expression and activation in rabbit parietal cells.
    Nandi J; Das PK; Zinkievich JM; Baltodano JD; Levine RA
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):127-34. PubMed ID: 18759857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parietal cell structure during inhibition of acid secretion.
    Helander HF
    Scand J Gastroenterol Suppl; 1984; 101():21-6. PubMed ID: 6599538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study with oxmetidine and ranitidine on acid secretion and gastrin release in the dog.
    Soldani G; Del Tacca M; Polloni A; Bernardini C; Martinotti E
    Int J Tissue React; 1984; 6(2):181-4. PubMed ID: 6145677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural transformation of gastric parietal cells reverting from the active to the resting state of acid secretion revealed in isolated rat gastric mucosa model processed by high-pressure freezing.
    Sawaguchi A; Aoyama F; Ohashi M; Ide S; Suganuma T
    J Electron Microsc (Tokyo); 2006 Apr; 55(2):97-105. PubMed ID: 16702177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.